Mild atopic dermatitis
Conditions
Interventions
Case series:application Atoderm Intensive Baume
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All subjects should satisfy the inclusive criteria below: 1. Subject aged from 18 to 75 (male or female); 2. Subject diagnosed as atopic by the UK Working Partys diagnostic criteria which is made by the China Atopic Dermatitis diagnosis and therapy guideline (2014); 3. Subjects with SCORAD ranging from 10 to 25 (including 10 and 25); 4. Subject who volunteer to participate in this study and signed the written informed consent form (ICF); 5. Subject who understand the contents of study and is able to participate in the study (determined by the investigator); 6. Subject who agrees to stop applying his/her habitual emollient and cleanser during the whole study period; 7. Subjects that did not take oral anti-inflammatory drugs within 4 weeks prior to enrollment in the study; 8. Subjects that did not applied anti-inflammatory drugs within 2 weeks before the enrollment in the study; 9. Subjects that did not take antihistamine 3 days before the enrollment in the study.
Exclusion criteria
Exclusion criteria: 1. Subject presenting AD with severe infection, cutaneous damage, effusion; 2. Subject presenting a cutaneous pathology other than AD (according to the investigators appreciation); 3. Subject presenting systemic diseases other than skin diseases that are not controlled by a medical doctor; 4. Pregnant woman or breast-feeding woman; 5. If the atopic subject need to use systemic glucocorticoid treatment for AD and/or other allergic symptoms; 6. Subject who will not stop his/her medication that is not permitted in the clinical study; 7. Subject with history of malignancy, HIV infection, autoimmune diseases and severe diabetes; 8. Subject with history of angina, severe cardiovascular and cerebrovascular complications, anaphylactic shock; 9. Subject participating in other clinical study before the screening visit (Day 0, D0) is not qualify for this study; 10. Subject with documented allergies to study product components; 11. Subject enrolled in another clinical trial during the study period; 12. Other conditions that the investigators considered that are not suitable for the clinical study; 13. Subject considered by the investigator to be unlikely to comply with the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of atopic dermatitis; | — |
Countries
China
Contacts
Public ContactAustin Zhang
BIODERMA(China)Co., Ltd.
Outcome results
None listed